Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Nifedipine Versus Intravenous Labetalol for Postpartum (PP) Hypertensive Emergency: A Randomized Clinical Trial (RCT)

NCT05139238 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT05139238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05139238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Nifedipine Versus Intravenous Labetalol for Postpartum (PP) Hypertensive Emergency: A Randomized Clinical Trial (RCT)
Lead sponsor
Columbia University
Phase
Phase 4
Overall status
Terminated
Start date
July 4, 2022
Completion date
August 21, 2025
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertensive emergency, postpartum preeclampsia, postpartum pregnancy-induced hypertension, pregnancy-induced hypertension in postpartum